These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 20945346

  • 1. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH, Jang SH, Kang BC, Kim HJ, Oh SH, Kong G.
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [Abstract] [Full Text] [Related]

  • 2. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
    Kong G, Chua SS, Yijun Y, Kittrell F, Moraes RC, Medina D, Said TK.
    Oncogene; 2002 Oct 17; 21(47):7214-25. PubMed ID: 12370811
    [Abstract] [Full Text] [Related]

  • 3. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 17; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 4. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E, Groner B, Barash I.
    Mol Cancer Res; 2002 Nov 17; 1(1):32-47. PubMed ID: 12496367
    [Abstract] [Full Text] [Related]

  • 5. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
    Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L.
    Oncogene; 2002 Aug 15; 21(36):5548-56. PubMed ID: 12165853
    [Abstract] [Full Text] [Related]

  • 6. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.
    Oncogene; 2000 Dec 07; 19(52):6007-14. PubMed ID: 11146552
    [Abstract] [Full Text] [Related]

  • 7. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 8. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 9. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, Turm H, Grisaru-Granovsky S, Suzuki H, Bar-Shavit R.
    Cancer Res; 2006 May 15; 66(10):5224-33. PubMed ID: 16707447
    [Abstract] [Full Text] [Related]

  • 10. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
    Michaelson JS, Leder P.
    Oncogene; 2001 Aug 23; 20(37):5093-9. PubMed ID: 11526497
    [Abstract] [Full Text] [Related]

  • 11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 12. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function.
    Radice GL, Sauer CL, Kostetskii I, Peralta Soler A, Knudsen KA.
    Differentiation; 2003 Aug 01; 71(6):361-73. PubMed ID: 12919105
    [Abstract] [Full Text] [Related]

  • 14. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
    Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS.
    J Cell Physiol; 2004 Nov 01; 201(2):266-76. PubMed ID: 15334661
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis in normal and neoplastic mammary gland development.
    Strange R, Metcalfe T, Thackray L, Dang M.
    Microsc Res Tech; 2001 Jan 15; 52(2):171-81. PubMed ID: 11169865
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS.
    Am J Pathol; 2005 Aug 15; 167(2):585-97. PubMed ID: 16049342
    [Abstract] [Full Text] [Related]

  • 17. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L, Bianco C, Raafat A, Abdallah W, Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan R, Hinck L, Salomon D.
    J Cell Sci; 2005 Oct 15; 118(Pt 20):4633-43. PubMed ID: 16176936
    [Abstract] [Full Text] [Related]

  • 18. Delayed mammary gland involution in MMTV-AKT1 transgenic mice.
    Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI.
    Oncogene; 2002 Jan 10; 21(2):198-206. PubMed ID: 11803463
    [Abstract] [Full Text] [Related]

  • 19. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 14; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.